Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells

Nabanita S Datta, Michael W Long

Open source

DOI
10.1016/s0301-472x(01)00780-9
Published
2002-02
Container
Experimental Hematology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0301-472x-01-00780-9,
  title = {Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells},
  author = {Nabanita S Datta and Michael W Long},
  year = {2002},
  journal = {Experimental Hematology},
  doi = {10.1016/s0301-472x(01)00780-9},
  url = {https://doi.org/10.1016/s0301-472x(01)00780-9}
}

RIS

TY  - JOUR
TI  - Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells
AU  - Nabanita S Datta
AU  - Michael W Long
PY  - 2002
JO  - Experimental Hematology
DO  - 10.1016/s0301-472x(01)00780-9
UR  - https://doi.org/10.1016/s0301-472x(01)00780-9
ER  - 

APA

Datta, N. S., & Long, M. W. (2002). Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells. Experimental Hematology. https://doi.org/10.1016/s0301-472x(01)00780-9

Source records